Irhythm Technologies Inc (IRTC) Stock Price, Quote & News

Company Profile

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG)...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 632 5700

Website: www.irhythmtech.com

Address:

699 8th Street, Suite 600, San Francisco, United States

healthcareguru Sep. 11 at 6:31 PM

$IRTC overbought…more interesting <$170

0 · Reply

StockConsultant Sep. 4 at 2:29 AM

$IRTC iRhythm Technologies stock, nice continuation breakout

0 · Reply

V_nbt Sep. 2 at 7:30 PM

$IRTC https://www.sprucepointcap.com/research/irhythm-technologies-inc

0 · Reply

ZacksResearch Sep. 2 at 5:52 PM

$IRTC just unveiled game-changing trial results! 🚀 The AMALFI study shows IRTC's Zio service boosts AFib detection by 26% compared to standard methods and cuts diagnosis time significantly, from 530 days to 103 days. This could drive physician adoption and revenue growth in AFib treatment. Discover how IRTC plans to capitalize on this breakthrough 👉 https://www.zacks.com/stock/news/2746241/irtc-unveils-positive-amalfi-trial-data-showing-higher-af-detection?cid=sm-stocktwits-2-2746241-body-10605&ADID=SYND_STOCKTWITS_TWEET_2_2746241_BODY_10605

0 · Reply

ZacksResearch Sep. 2 at 4:52 PM

$IRTC drops strong AMALFI trial data ❤️‍🩹 Zio monitoring delivered higher AF detection and faster diagnosis — a clear edge in cardiac care. See the full trial impact here 👉 https://www.zacks.com/stock/news/2746241/irtc-unveils-positive-amalfi-trial-data-showing-higher-af-detection?cid=sm-stocktwits-2-2746241-teaser-10566&ADID=SYND_STOCKTWITS_TWEET_2_2746241_TEASER_10566

0 · Reply

JarvisFlow Aug. 28 at 11:00 AM

Needham has updated their rating for iRhythm Technologies ( $IRTC ) to Buy with a price target of 193.

0 · Reply

V_nbt Aug. 27 at 7:58 PM

$IRTC not even a short report can stop this . go bby 200

0 · Reply

TheQuantVision Aug. 27 at 10:07 AM

$IRTC building a base, watching for breakout confirmation.

0 · Reply

V_nbt Aug. 25 at 5:46 PM

$IRTC

0 · Reply

JarvisFlow Aug. 21 at 6:09 PM

Citigroup has updated their rating for iRhythm Technologies ( $IRTC ) to Buy with a price target of 183.

0 · Reply

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 29, 2025, 7:00 AM EDT - 15 days ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 20, 2025, 4:30 PM EDT - 23 days ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

Aug 18, 2025, 12:53 PM EDT - 25 days ago

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

Aug 18, 2025, 8:05 AM EDT - 26 days ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Jul 31, 2025, 9:49 PM EDT - 6 weeks ago

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 6 weeks ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 25, 2025, 6:35 PM EDT - 7 weeks ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 17, 2025, 4:30 PM EDT - 2 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 11, 2025, 10:12 PM EDT - 2 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 7, 2025, 8:30 AM EDT - 2 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jun 23, 2025, 8:30 AM EDT - 2 months ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 17, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 3 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Jun 8, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Jun 5, 2025, 10:00 AM EDT - 3 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

May 2, 2025, 1:24 PM EDT - 4 months ago

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

May 1, 2025, 9:14 PM EDT - 4 months ago

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:10 PM EDT - 4 months ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 4 months ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 4 months ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 5 months ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 5 months ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Mar 31, 2025, 8:05 AM EDT - 5 months ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Feb 21, 2025, 12:23 AM EST - 7 months ago

iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:05 PM EST - 7 months ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 14, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Feb 13, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out

Feb 12, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 7 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 4:05 PM EST - 7 months ago

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 14, 2025, 10:00 AM EST - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Jan 13, 2025, 8:30 AM EST - 8 months ago

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out

Dec 30, 2024, 4:30 PM EST - 9 months ago

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 10 months ago

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

Nov 18, 2024, 8:15 AM EST - 10 months ago

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

Nov 5, 2024, 4:30 PM EST - 11 months ago

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

Oct 30, 2024, 8:26 PM EDT - 11 months ago

iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 5:15 PM EDT - 11 months ago

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Oct 30, 2024, 4:08 PM EDT - 11 months ago

iRhythm Technologies Announces Third Quarter 2024 Financial Results

Oct 28, 2024, 8:02 AM EDT - 11 months ago

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

Oct 22, 2024, 1:18 PM EDT - 11 months ago

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

healthcareguru Sep. 11 at 6:31 PM

$IRTC overbought…more interesting <$170

0 · Reply

StockConsultant Sep. 4 at 2:29 AM

$IRTC iRhythm Technologies stock, nice continuation breakout

0 · Reply

V_nbt Sep. 2 at 7:30 PM

$IRTC https://www.sprucepointcap.com/research/irhythm-technologies-inc

0 · Reply

ZacksResearch Sep. 2 at 5:52 PM

0 · Reply

ZacksResearch Sep. 2 at 4:52 PM

0 · Reply

JarvisFlow Aug. 28 at 11:00 AM

Needham has updated their rating for iRhythm Technologies ( $IRTC ) to Buy with a price target of 193.

0 · Reply

V_nbt Aug. 27 at 7:58 PM

$IRTC not even a short report can stop this . go bby 200

0 · Reply

TheQuantVision Aug. 27 at 10:07 AM

$IRTC building a base, watching for breakout confirmation.

0 · Reply

V_nbt Aug. 25 at 5:46 PM

$IRTC

0 · Reply

JarvisFlow Aug. 21 at 6:09 PM

Citigroup has updated their rating for iRhythm Technologies ( $IRTC ) to Buy with a price target of 183.

0 · Reply

MaverikIT Aug. 20 at 1:59 PM

$EW $IRTC kinder heart will keep you having to visit $HCA +4.30 $THC

0 · Reply

MaverikIT Aug. 20 at 1:57 PM

@rxptgh $EW +2.24 $IRTC +3.06 - da kinder heart

0 · Reply

JarvisFlow Aug. 20 at 12:30 PM

B of A Securities updates rating for iRhythm Technologies ( $IRTC ) to Buy, target set at 200.

0 · Reply

V_nbt Aug. 18 at 2:16 PM

$IRTC good time to come out !

0 · Reply

DonCorleone77 Aug. 18 at 1:12 PM

$IRTC Spruce Point says it's short iRhythm, sees 40%-70% potential LT downside https://www.sprucepointcap.com/research/irhythm-technologies-inc

0 · Reply

OpenOutcrier Aug. 18 at 1:12 PM

$IRTC (-3.5% pre) Spruce Point Capital Management Issues "Strong Sell" Research Opinion On iRhythm Technologies https://ooc.bz/l/74288

0 · Reply

lipmaz Aug. 17 at 12:05 AM

$MASI or $IRTC you can only choose one?

0 · Reply

StockConsultant Aug. 14 at 1:26 PM

$IRTC iRhythm Technologies stock, watch for a bull flag breakout at https://stockconsultant.com/?IRTC

0 · Reply

stockstelegraph Aug. 5 at 10:33 AM

📈 Analyst Actions – Aug 1, 2025 🔍 Fresh ratings and target updates just in: 💠 $IRTC – Buy maintained by Needham, PT raised from $151 → $180 💠 $PCOR – Overweight maintained by Piper Sandler, PT raised to $82 💠 $ARGX – Buy maintained by HC Wainwright, PT up to $774 💠 $GORO – Buy reaffirmed with PT at $1.50 🔻 $MX – Buy maintained by Needham, PT cut from $6 → $5.5 #StockMarket #AnalystRatings #PTUpdates #IRTC #PCOR #ARGX #GORO #MX

0 · Reply

BigWaveTrading Aug. 4 at 8:06 PM

$SPY $QQQ $RDDT $IRTC $GFI Congratulations to anyone that got long $GFI. It worked a little too well. The gap was above my personal GTC BUY STOP and LIMIT order. Trigger but no fill. That's trading. Pocket Pivot Point signal off 50 SMA should have been proper entry on 7/25. Lesson learned.

0 · Reply

WallStreetBuyDip Aug. 3 at 1:10 AM

$IRTC Trading at $164.97, quite a jump from recent days' lows around $57.07 with an average volume of 495,948.

0 · Reply

BigWaveTrading Aug. 2 at 7:42 PM

Indices Crack 21 Exponential Moving Averages As Distribution Days Pile-Up And Gold Stocks Shine In this video lesson I review the yellow then red flag warnings given to memebers of Big Wave Trading the past two weeks before today's session. I then take a look at the indices $SPY $QQQ, new leading stocks $RDDT $IRTC, and review a new swing trade setup in a leading gold stock $GFI with stellar fundamentals for Monday's session. https://www.youtube.com/watch?v=8fWtlwQV1b0

0 · Reply

Market Cap	5.82B
Revenue (ttm)	591.84M
Net Income (ttm)	-113.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.14%
Debt to Equity Ratio	0.00

Volume	232,400
Avg Vol	468,134
Day's Range	N/A - N/A
Shares Out	32.13M
Stochastic %K	62%
Beta	1.10
Analysts	Strong Sell
Price Target	$180.00